However, the putative evolutionary benefits come at a cost of increased lifetime risk for kidney disease in individuals with two copies of these variants (i.e., G1/G1, G2/G2, or G1/G2, identified as APOL1 high-risk genotypes). This evidence concerns the gene APOL1 and kidney disorder.